D. L. Patrick, L. B. Burke, and J. H. Powers, Patient-reported outcomes to support medical product labeling claims: FDA perspective, Value Health, vol.10, pp.125-162, 2007.

M. E. Porter, S. Larsson, and T. H. Lee, Standardizing Patient Outcomes Measurement, N Engl J Med, vol.374, pp.504-510, 2016.

, Department of Health and Human Services FDA Center for Devices and Radiological Health.. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance, Health Qual Life Outcomes, vol.4, p.79, 2006.

S. Briançon and M. Kessler, Qualité de vie et maladies rénales chroniques

E. Vodicka, K. Kim, E. B. Devine, A. Gnanasakthy, J. F. Scoggins et al., Inclusion of patientreported outcome measures in registered clinical trials: Evidence from ClinicalTrials. gov, Contemp Clin Trials, vol.43, pp.1-9, 2007.

D. Cella, I. Wiklund, S. Shumaker, and N. Aaronson, Integrating health-related quality of life into cross-national clinical trials, Qual Life Res, vol.2, pp.1-9, 1993.

K. Ahmed, D. Kyte, and T. Keeley, Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol, BMJ Open, vol.6, issue.9, p.12863, 2016.

S. Ahmed, R. A. Berzon, and D. A. Revicki, The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy, Med Care, vol.50, issue.12, pp.1060-70, 2012.

D. G. Kyte, H. Draper, J. Ives, C. Liles, and A. Gheorghe, Patient Reported Outcomes (PROs) in Clinical Trials: Is 'In-Trial'Guidance Lacking? A Systematic Review, PLoS One, vol.8, issue.4, p.46068, 2013.

F. Efficace, P. Fayers, and A. Pusic, Quality of patientreported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials, Cancer, vol.121, issue.18, pp.3335-3375, 2015.

E. Basch, The missing voice of patients in drug-safety reporting, N Engl J Med, vol.362, pp.865-874, 2010.

A. Trotti, A. D. Colevas, A. Setser, and E. Basch, Patient-reported outcomes and the evolution of adverse event reporting in oncology, J Clin Oncol, vol.25, pp.5121-5128, 2007.

G. Gravis, P. Marino, and F. Joly, Patients' selfassessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15), Eur J Cancer, vol.50, pp.953-62, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01917876

F. Montemurro, G. Mittica, and C. Cagnazzo, Self-evaluation of adjuvant chemotherapyrelated adverse effects by patients with breast cancer, JAMA Oncol, vol.2, pp.445-52, 2016.

D. Maio, M. Gallo, C. Leighl, and N. B. , Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, J Clin Oncol, vol.33, pp.910-915, 2015.

M. A. Petersen, H. Larsen, L. Pedersen, N. Sonne, and M. Groenvold, Assessing health-related quality of life in palliative care: comparing patient and physician assessments, Eur J Cancer, vol.42, pp.1159-66, 2006.

E. K. Fromme, K. M. Eilers, M. Mori, Y. Hsieh, and T. M. Beer, How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30, J Clin Oncol, vol.22, pp.3485-90, 2004.

E. Basch, B. B. Reeve, and S. A. Mitchell, Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE), J Natl Cancer Inst, vol.106, issue.9, 2014.

A. C. Dueck, T. R. Mendoza, and S. A. Mitchell, Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), JAMA Oncol, vol.1, pp.1051-1060, 2015.

B. B. Reeve, S. A. Mitchell, and A. C. Dueck, Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials, J Natl Cancer Inst, vol.106, issue.7, 2014.

G. Macquart-moulin, P. Viens, and M. L. Bouscary, Discordance between physicians' estimations and breast cancer patients' selfassessment of side-effects of chemotherapy: an issue for quality of care, Br J Cancer, vol.76, pp.1640-1645, 1997.

E. A. Laugsand, M. Sprangers, K. Bjordal, F. Skorpen, S. Kaasa et al., Health care providers underestimate symptom intensities of cancer patients: a multicenter European study, Health Qual Life Outcomes, vol.8, p.104, 2010.

N. Black, Patient reported outcome measures could help transform healthcare, BMJ, vol.346, p.167, 2013.

S. Duran, B. Spire, and F. Raffi, Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART, HIV Clin Trials, vol.2, pp.38-45, 2001.

B. Spire, S. Duran, and M. Souville, Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Soc Sci Med, vol.54, pp.1481-96, 2002.

L. Collette, G. Van-andel, and A. Bottomley, Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group, J Clin Oncol, vol.22, pp.3877-85, 2004.

F. Efficace, A. Bottomley, and E. F. Smit, Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975, Ann Oncol, vol.17, pp.1698-704, 2006.

S. H. Park, M. S. Cho, and Y. S. Kim, Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy, Qual Life Res, vol.17, pp.207-221, 2008.

F. Bonnetain, X. Paoletti, and S. Collette, Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials, Qual Life Res, vol.17, pp.831-874, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00363732

M. Diouf, T. Filleron, and J. Barbare, The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma, J Hepatol, vol.58, pp.509-530, 2013.

G. Velikova, L. Booth, and A. B. Smith, Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial, J Clin Oncol, vol.22, pp.714-738, 2004.

D. Berry, B. Blumenstein, and B. Halpenny, Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial, J Clin Oncol, vol.29, p.10291035, 2011.

M. Neumann, F. Edelhäuser, and G. L. Kreps, Can patient-provider interaction increase the effectiveness of medical treatment or even substitute it?-an exploration on why and how to study the specific effect of the provider, Patient Educ Couns, vol.80, pp.307-321, 2010.

M. Neumann, M. Wirtz, and E. Bollschweiler, Determinants and patient-reported long-term outcomes of physician empathy in oncology: a structural equation modelling approach, Patient Educ Couns, vol.69, pp.63-75, 2007.

G. Gravis, C. Protière, and F. Eisinger, Full access to medical records does not modify anxiety in cancer patients: results of a randomized study, Cancer, vol.117, issue.20, pp.4796-804, 2011.

J. M. Blazeby, K. Avery, and M. Sprangers, Health-related quality of life measurement in randomized clinical trials in surgical oncology, J Clin Oncol, vol.24, pp.3178-86, 2006.

F. Hamdy and J. Donovan, Patient-reported outcomes following treatment for localized prostate cancer. Helping decision making for patients and their physicians, JAMA, vol.317, issue.11, pp.1121-1124, 2017.

J. S. Temel, Early palliative care for patients with metastatic non-small-cell lung cancer, N Engl J Med, vol.363, pp.733-775, 2010.

M. A. Bakitas, T. D. Tosteson, and Z. Li, Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial, J Clin Oncol, vol.33, pp.1438-1483, 2015.

C. Zimmermann, Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial, Lancet, vol.383, pp.1721-1751, 2014.

E. Basch, A. M. Deal, and A. C. Dueck, Overall survival results of a trial assessing patientreported outcomes for symptom monitoring during routine cancer treatment, JAMA, 2017.

F. Denis, C. Lethrosne, and N. Pourel, Randomized trial comparing a webmediated follow-up with routine surveillance in lung cancer patients, J Natl Cancer Inst, vol.109, issue.9, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01611175

L. S. Rotenstein, R. S. Huckman, and N. W. Wagle, Making Patients and Doctors Happier -The Potential of Patient-Reported Outcomes, N Engl J Med, vol.377, pp.1309-1321, 2017.